Hyaluronidase and rituximab and Mio-Rel
Determining the interaction of Hyaluronidase and rituximab and Mio-Rel and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: Rituximab and Hyaluronidase
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Mio-Rel (Injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronidase and rituximab-Miochol-E
- Hyaluronidase and rituximab-Miostat
- Hyaluronidase and rituximab-Mipomersen
- Hyaluronidase and rituximab-Mipomersen Sodium
- Hyaluronidase and rituximab-Mipomersen Subcutaneous
- Hyaluronidase and rituximab-Mirabegron
- Mio-Rel-Hyaluronidase and trastuzumab
- Mio-Rel-Hyaluronidase injection
- Mio-Rel-Hyaluronidase Injection (Human)
- Mio-Rel-Hyaluronidase Subcutaneous, Injection
- Mio-Rel-Hyate:C
- Mio-Rel-Hybrisil